Study of T-cell immunoglobulin- and mucin-domain-containing molecule 3 polymorphisms in Egyptian childhood immune thrombocytopenic purpura

被引:0
作者
Radwan E.R. [1 ]
Youssef E.A. [1 ]
Sewelam N.I. [1 ]
Goda R.I.M. [2 ]
Arnaout H.H. [1 ]
机构
[1] Clinical and Chemical Pathology Department, Cairo University, Cairo, 11451
[2] Department of Paediatric Haematology, Cairo University, Cairo
关键词
Immune thrombocytopenic purpura; Thrombocytopenia; TIM-3; polymorphisms;
D O I
10.1007/s00580-013-1716-6
中图分类号
学科分类号
摘要
The T-cell immunoglobulin- and mucin-domain-containing molecules (TIMs) influence immune regulation. TIM-3, a transmembrane protein expressed on terminally differentiated Th1 cells, is a central regulator of T-cell responses. Dysfunctional T-lymphocyte immunity plays an important role in the pathophysiology of immune thrombocytopenic purpura (ITP). The study aimed to evaluate the possible contribution of TIM-3 polymorphisms to the pathogenesis of ITP and their relation to age of disease onset, clinical course, and response to therapy. Genotyping of TIM-3 -1516G>T, -574T>G, and 4259G>T was performed in 100 childhood ITP patients and 210 healthy individuals by polymerase chain reaction-restriction fragment length polymorphism. No significant differences existed in genotype and allele distributions between patients and controls in all three sites. There was a statistically significant association between the -574T>G T/T genotype and both a lower platelet count and a younger age of disease onset (p = 0.001). A near significant association was found between the 4259G>T T/T genotype and increased disease severity at diagnosis and also between both -574T>G G/G and 4259G>T T/T and a better quality of response (p = 0.07). The study did not detect a risk association between the TIM-3 single-nucleotide polymorphisms and ITP susceptibility. However, it is associated with an earlier disease onset and severity as indicated by the lower platelet count. © 2013 Springer-Verlag London.
引用
收藏
页码:933 / 939
页数:6
相关论文
共 26 条
  • [1] Anderson A.C., Anderson D.E., Bregoli L., Hastings W.D., Kassam N., Lei C., Chandwaskar R., Karman J., Su E.W., Hirashima M., Bruce J.N., Kane L.P., Kuchroo V.K., Hafler D.A., Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells, Science, 18, pp. 1141-1143, (2007)
  • [2] Anderson A.C., Lord G.M., Dardalhon V., Lee D.H., Sabatos-Peyton C.A., Glimcher L.H., Kuchroo V.K., T-bet, a Th1 transcription factor regulates the expression of Tim-3, Eur J Immunol, 40, pp. 859-866, (2010)
  • [3] Chae S.C., Park Y.R., Shim S.C., Yoon K.S., Chung H.T., The polymorphisms of Th1 cell surface gene Tim-3 are associated in a Korean population with rheumatoid arthritis, Immunol Lett, 95, pp. 91-95, (2004)
  • [4] Chae S.C., Song J.H., Pounsambath P., Yuan H.Y., Lee J.H., Kim J.J., Lee Y.C., Chung H.T., Molecular variations in Th1-specific cell surface gene Tim-3, Exp Mol Med, 36, pp. 274-278, (2004)
  • [5] Chae S.C., Park Y.R., Lee Y.C., Lee J.H., Chung H.T., The association of TIM-3 gene polymorphism with atopic disease in Korean population, Hum Immunol, 65, pp. 1427-1431, (2004)
  • [6] Cines D.B., Blanchette V.S., Immune thrombocytopenic purpura, N Engl J Med, 346, pp. 995-1008, (2002)
  • [7] DeKruyff R.H., Bu X., Ballesteros A., Santiago C., Chim Y.L., Lee H.H., Karisola P., Pichavant M., Kaplan G.G., Umetsu D.T., Freeman G.J., Casasnovas J.M., T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells, J Immunol, 184, pp. 1918-1930, (2010)
  • [8] Du W.T., Zhao H.F., Xu J.H., Gu D.S., Xue F., Ge J., Dong X.W., Chen Z.P., Zhou Z.P., Yang R.C., The role of T-cell immunoglobulin- and mucin-domain-containing molecule-3 polymorphisms in idiopathic thrombocytopenic purpura, Hum Immunol, 70, pp. 398-402, (2009)
  • [9] Golden-Mason L., Palmer B.E., Kassam N., Townshend-Bulson L., Livingston S., McMahon B.J., Castelblanco N., Kuchroo V., Gretch D.R., Rosen H.R., Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells, J Virol, 83, pp. 9122-9130, (2009)
  • [10] Hastings W.D., Anderson D.E., Kassam N., Koguchi K., Greenfield E.A., Kent S.C., Zheng X.X., Strom T.B., Hafler D.A., Kuchroo V.K., TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines, Eur J Immunol, 39, pp. 2492-2501, (2009)